We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$168M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$156M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$23.4M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$19M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$15.1M

Top Sells

Rank Stock Value
1
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$52.3M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$22.7M
3
V icon
Visa
V
+$21.1M
4
AAPL icon
Apple
AAPL
+$20.2M
5
MSFT icon
Microsoft
MSFT
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMRS
3151
DELISTED
Amyris Inc.
AMRS
$2K ﹤0.01%
694
+667
+2,470% +$2.47K
TCFC
3152
DELISTED
The Community Financial Corporation Common Stock
TCFC
$2K ﹤0.01%
56
+15
+37% +$508
LMST
3153
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$2K ﹤0.01%
+124
New +$2K
NVCN
3154
DELISTED
Neovasc Inc.
NVCN
$2K ﹤0.01%
12
+8
+200% +$680
CLVS
3155
DELISTED
Clovis Oncology, Inc.
CLVS
$2K ﹤0.01%
222
-299
-57% -$2.17K
PHAS
3156
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$2K ﹤0.01%
373
-1,329
-78% -$5.47K
GBL
3157
DELISTED
GAMCO Investors, Inc.
GBL
$2K ﹤0.01%
99
-712
-88% -$12.6K
MOHO
3158
DELISTED
ECMOHO Limited American Depositary Shares
MOHO
$2K ﹤0.01%
+295
New +$2.47K
CTT
3159
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$2K ﹤0.01%
200
-1,606
-89% -$18.3K
MNDT
3160
DELISTED
Mandiant, Inc. Common Stock
MNDT
$2K ﹤0.01%
100
-24
-19% -$385
AUTO
3161
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$2K ﹤0.01%
+687
New +$1.78K
OBCI
3162
DELISTED
Ocean Bio-Chem Inc
OBCI
$2K ﹤0.01%
519
+405
+355% +$1.38K
TREC
3163
DELISTED
Trecora Resources
TREC
$2K ﹤0.01%
348
+138
+66% +$1.13K
HBP
3164
DELISTED
Huttig Building Products, Inc.
HBP
$2K ﹤0.01%
1,470
-14,470
-91% -$28.3K
GFED
3165
DELISTED
Guaranty Federal Bancshares In
GFED
$2K ﹤0.01%
80
-129
-62% -$3.18K
LEVL
3166
DELISTED
Level One Bancorp, Inc. Common Stock
LEVL
$2K ﹤0.01%
76
-2,798
-97% -$68.7K
ACBI
3167
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$2K ﹤0.01%
116
-1,826
-94% -$33.5K
CNBKA
3168
DELISTED
Century Bancorp Inc/Mass
CNBKA
$2K ﹤0.01%
24
-127
-84% -$11.1K
GGO
3169
DELISTED
The Gabelli Go Anywhere Trust
GGO
$2K ﹤0.01%
+100
New +$1.54K
CATM
3170
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$2K ﹤0.01%
46
-254
-85% -$9.64K
TPCO
3171
DELISTED
Tribune Publishing Company Common Stock
TPCO
$2K ﹤0.01%
150
-866
-85% -$9.11K
QEP
3172
DELISTED
QEP RESOURCES, INC.
QEP
$2K ﹤0.01%
500
-17,168
-97% -$59.8K
CBMG
3173
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$2K ﹤0.01%
130
-1,073
-89% -$17.9K
FIT
3174
DELISTED
Fitbit, Inc. Class A common stock
FIT
$2K ﹤0.01%
367
-545
-60% -$3.2K
RMG.U
3175
DELISTED
RMG Acquisition Corp.
RMG.U
$2K ﹤0.01%
200
– –
125 126
127
128 129

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.